世界の大腸がんのスクリーニングと診断市場

Report Highlights

The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.

大腸がんのスクリーニングと診断検査サービスの世界市場は、2024年から2029年にかけて年平均成長率（CAGR）2.9%で拡大し、2024年の400億ドルから2029年には461億ドルに達すると予測されています。

Summary:

The increasing incidence of colorectal cancer, rise in demand for non-invasive colorectal cancer screening, growing need for early cancer detection to lower treatment cost, advances in genomics and molecular diagnostics, and rising financial burden on healthcare are key factors driving the market’s growth. However, the limited sensitivity of non-invasive testing methods, sample collection challenges, and stringent regulations might hinder the market’s growth in the next five years.

大腸がんの発生率の増加、非侵襲的大腸がんスクリーニングの需要の増加、治療費の削減を目的とした早期がん検出の必要性の高まり、ゲノミクスと分子診断の進歩、医療に対する財政的負担の増加は、市場の成長を牽引する主な要因です。ただし、非侵襲的検査方法の感度の限界、サンプル収集の課題、厳格な規制により、今後 5 年間の市場の成長が妨げられる可能性があります。

This report segments the global market by test type, end user, and region. By test type, the colonoscopy and sigmoidoscopy segment held the largest market share in 2023, and this segment is expected to grow at a CAGR of 1.7% during the forecast period.

In terms of end users, the hospital and clinic segment is forecast to grow at a CAGR of 2.6% during the forecast period. This segment dominated with 69.3% of the market in 2023 and is forecast to reach a value of $31.4 billion by the end of 2029.

North America held the largest regional market share, with 60.8% in 2023. An increasing number of screening tests for colorectal cancer coupled with the significant regional presence of key product manufacturers are responsible for a large share.

Leading product manufacturers in the global market include Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., Guardant Health, and New Horizon Health.

Report Scope

This report summarizes the colorectal cancer screening and diagnostic testing service market, including a market snapshot and company profiles of leading product manufacturers/service providers. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical market players’ financials, product portfolios, and recent activities.

このレポートは、大腸がんのスクリーニングおよび診断検査サービス市場の概要をまとめたもので、市場のスナップショットや主要な製品メーカー/サービスプロバイダーの企業プロファイルが含まれています。各セグメントに関する詳細な情報を含む包括的な市場の内訳を提供します。レポートの概要セクションでは、推進要因、課題、機会など、市場の傾向と動向について説明します。業界の新興技術と開発に関する情報を提供します。レポートでは、重要な市場プレーヤーの財務、製品ポートフォリオ、最近の活動も分析します。

BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading product manufacturers/service providers in the colorectal cancer screening and diagnostic testing service industry, including Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics.

BCC リサーチは、各市場とその用途を分析、予測し、今後 5 年間の見通しも示しました。レポートには、富士フイルムホールディングス株式会社、オリンパス株式会社、Exact Sciences Corporation、Danaher Corporation、Guardant Health、New Horizo​​n Health、Quest Diagnostics など、大腸がんスクリーニングおよび診断検査サービス業界の大手製品メーカー/サービスプロバイダーのプロフィールも掲載されています。

The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Regional analysis is further segregated:

– North America: The U.S., Canada, and Mexico.

– Europe: Germany, the U.K., France, Italy, Spain, and the Rest of Europe.

– Asia-Pacific: China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific.

Data for market estimates have been provided for 2021 and 2022 as the historical years and 2023 as the base year, with the forecast through 2029.

Report Includes

– 37 data tables and 71 additional tables

– Analyses of trends in the global market for colorectal cancer screening and diagnostics, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Estimates and forecasts of the market size by type, end user and geographic region

– Discussion of emerging technologies and developments, and the macroeconomic factors affecting the market

– Coverage of stages, etiology, pathophysiology, and risk factors of colorectal cancer, and discussion on its diagnosis, regulatory framework and reimbursement scenarios

– Information on product pipeline, approvals, launches and expansions and funding and grants in the medical industry

– Review of patent data and other new developments

– Discussion of ESG challenges and practices of the industry

– Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews

– Information on recent mergers and acquisitions, expansions, collaborations, investments, and divestments

– Company profiles of major players within the industry, including Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., and Guardant Health

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Insights

Chapter 2 Market Overview

Disease Area Overview

Stages of Colorectal Cancer

Stage 0

Stage I

Stage II

Stage III

Stage IV

Etiology

Genetic Factors

Environmental Factors

Pathophysiology

Germline Mutations

Sporadic Mutations

Metastasis

Clinical Implications

Risk Factors

Inherited Syndromes

Lynch Syndrome (HNPCC)

Familial Adenomatous Polyposis (FAP)

Diagnosis

Prognosis

Types of Colorectal Cancer

Colorectal Adenocarcinoma

Gastrointestinal Stromal Tumors (GISTs)

Carcinoids

Turcot Syndrome

Peutz-Jeghers Syndrome (PJS)

Familial Colorectal Cancer (FCC)

Juvenile Polyposis Syndrome (JPS)

Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

MUTYH-Associated Polyposis (MAP)

Market Definition

Inclusion and Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Market Introduction

The Road Ahead

Global Prevalence of Colorectal Cancer

Industry Outlook: Regulatory Framework

Regulatory Framework in the U.S.

Regulatory Framework in Europe

Regulatory Framework in the Asia-Pacific Region

Regulatory Landscape in Latin America

Reimbursement Scenarios

Colonoscopy and Sigmoidoscopy Tests

Stool DNA Test

Fecal Immunochemical Tests (FIT)

Fecal Occult Blood Tests (FOBT)

Blood-based/Biomarker Tests

Product Pipeline

Comparison of Colorectal Cancer Screening and Diagnostic Tests

Colonoscopy Tests

Sigmoidoscopy Tests

Fecal Immunochemical Tests (FIT)

Guaiac Fecal Occult Blood Tests (gFOBT)

Stool DNA Tests

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Market Drivers

Increasing Incidence of Colorectal Cancer

Growing Financial Burden

Advances in Genomics and Molecular Diagnostics

Rise in Demand for Non-Invasive Colorectal Cancer Screening

Growing Need for Early Cancer Detection to Lower Treatment Costs

Market Restraints

Limited Sensitivity of Non-Invasive Testing Methods

Sample Collection Challenges

Stringent Regulations

Market Opportunities

Global Expansion of Colorectal Cancer Screening Programs

Emerging Economies Proposing Significant Untapped Potential

Chapter 4 Emerging Technologies and Developments

Introduction

Multimodal Approaches to Colorectal Cancer Screening

Development of At-Home Colorectal Cancer Screening Kits

Emerging Use of Gut Microbiota in Colorectal Cancer Diagnosis

Adoption of Artificial Intelligence (AI)

Digital Health Interventions

Multicancer Detection (MCD) Assays

Development of Self-Propelled Colonoscopes

Aer-O-Scope Colonoscope

ColonoSight

Chapter 5 Market Segmentation Analysis

Key Market Trends

Segmentation Breakdown

Global Market for Colorectal Cancer Screening and Diagnostic Testing Services

Market Analysis by Test Type

Colonoscopy and Sigmoidoscopy Tests

Stool DNA Tests

Market Size and Forecast

Blood-Based/Biomarker Tests

Fecal Occult Blood Tests (FOBT)

Fecal Immunochemical Tests (FIT)

Market Analysis by End User

Hospitals and Clinics

Diagnostic Laboratories

Ambulatory Centers

At-home Care

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific Region

Rest of the World

Chapter 6 Competitive Intelligence

Competitive Landscape

Partnerships and Collaborations

Acquisitions

Business Expansions

Funding and Grants

Product Approvals, Launches and Expansions

Regulatory and Legal Activities

Medicare and Insurance Coverage

Chapter 7 Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market

Introduction

Sustainability

Concluding Remarks from BCC

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

DANAHER CORP.

DIACARTA

EIKEN CHEMICAL CO. LTD.

EXACT SCIENCES CORP.

FREENOME HOLDINGS INC.

FUJIFILM HOLDINGS CORP.

GI-VIEW

GUARDANT HEALTH

HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD.

LABORATORY CORPORATION OF AMERICA HOLDINGS

LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.

MAINZ BIOMED N.V.

NOVIGENIX SA

OLYMPUS CORP.

QUEST DIAGNOSTICS INC.

QUIDELORTHO CORP.

List of Tables

Summary Table : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 1 : Stage II Substages of Colorectal Cancer

Table 2 : Stage III Substages of Colorectal Cancer

Table 3 : Stage IV Substages of Colorectal Cancer

Table 4 : Regulatory Landscape for Different Parameters for Key Countries

Table 5 : Colonoscopy and Sigmoidoscopy Test Reimbursements, by Country, 2024

Table 6 : Stool DNA Test Reimbursements, by Country, 2024

Table 7 : Fecal Immunochemical Test Reimbursements, by Country, 2024

Table 8 : Fecal Occult Blood Test Reimbursements, by Country, 2024

Table 9 : Blood-based/Biomarker Test Reimbursements, by Country, 2024

Table 10 : Cancer Screening and Diagnostic Product Pipeline, 2024

Table 11 : Characteristics of CRC Screening Tests Currently Available in the U.S., 2024

Table 12 : Characteristics of Recommended Colorectal Cancer Screening Tests, 2024

Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022

Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011

Table 15 : Examples of Product Launches and Approval in the Asia-Pacific Region, 2022

Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029

Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029

Table 18 : Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, Through 2029

Table 19 : Global Market for Stool DNA Tests, by Region, Through 2029

Table 20 : Global Market for Blood-Based/Biomarker Tests, by Region, Through 2029

Table 21 : Global Market for Fecal Occult Blood Tests (FOBT), by Region, Through 2029

Table 22 : Global Market for Fecal Immunochemical Tests (FIT), by Region, Through 2029

Table 23 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029

Table 24 : Global Market for Hospitals and Clinics in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 25 : Global Market for Diagnostic Laboratories in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 26 : Global Market for Ambulatory Centers in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 27 : Global Market for At-home Care in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 28 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029

Table 29 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029

Table 30 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029

Table 31 : North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029

Table 32 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029

Table 33 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029

Table 34 : European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029

Table 35 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029

Table 36 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029

Table 37 : Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029

Table 38 : ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029

Table 39 : ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029

Table 40 : Top Products and Their Manufacturers in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2023

Table 41 : Select Strategic Alliances in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 42 : Select Acquisitions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 43 : Major Business Expansion Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 44 : Major Grants and Funding Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 45 : Major Product Approvals, Launches, and Expansions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 46 : Major Regulatory and Legal Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2024

Table 47 : Major Medicare and Insurance Coverage in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024

Table 48 : Recent ESG Highlights from Select Testing Services Providing Companies

Table 49 : ESG Rankings for a Few Service-Providing Companies, 2024

Table 50 : ESG Rankings for Major Product Manufacturing Companies, 2024

Table 51 : Information Sources for this Report

Table 52 : Glossary of Terms Used in the Colorectal Cancer Screening and Diagnostic Testing Service Market

Table 53 : Danaher Corp.: Company Snapshot

Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 55 : Danaher Corp.: Product Portfolio

Table 56 : Danaher Corp.: News/Key Developments, 2022

Table 57 : DiaCarta: Company Snapshot

Table 58 : DiaCarta: Product Portfolio

Table 59 : DiaCarta: News/Key Developments, 2023

Table 60 : Eiken Chemical Co. Ltd.: Company Snapshot

Table 61 : Eiken Chemical Co. Ltd.: Financial Performance, FY 2022 and 2023

Table 62 : Eiken Chemical Co. Ltd.: Product Portfolio

Table 63 : Eiken Chemical Co. Ltd.: News/Key Developments, 2022

Table 64 : Exact Sciences Corp.: Company Snapshot

Table 65 : Exact Sciences Corp.: Financial Performance, FY 2022 and 2023

Table 66 : Exact Sciences Corp.: Product Portfolio

Table 67 : Exact Sciences Corp.: News/Key Developments, 2022-2024

Table 68 : Freenome Holdings Inc.: Company Snapshot

Table 69 : Freenome Holdings Inc.: News/ Key Developments, 2023 and 2024

Table 70 : Fujifilm Holdings Corp.: Company Snapshot

Table 71 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023

Table 72 : Fujifilm Holdings Corp.: Product Portfolio

Table 73 : GI-View: Company Snapshot

Table 74 : GI-View: Product Portfolio

Table 75 : Guardant Health: Company Snapshot

Table 76 : Guardant Health: Financial Performance, FY 2022 and 2023

Table 77 : Guardant Health: Product Portfolio

Table 78 : Guardant Health: News/Key Developments, 2024

Table 79 : Hangzhou NovaHealth Technology Co. Ltd.: Company Snapshot

Table 80 : Hangzhou NovaHealth Technology Co. Ltd.: Financial Performance, FY 2021 and 2022

Table 81 : Hangzhou NovaHealth Technology Co. Ltd.: Product Portfolio

Table 82 : Hangzhou NovaHealth Technology Co. Ltd.: News/Key Developments, 2022

Table 83 : Laboratory Corporation of America Holdings: Company Snapshot

Table 84 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023

Table 85 : Laboratory Corporation of America Holdings: Product Portfolio

Table 86 : Laboratory Corporation of America Holdings: News/Key Developments, 2024

Table 87 : Lepu Medical Technology (Beijing) Co. Ltd.: Company Snapshot

Table 88 : Lepu Medical Technology (Beijing) Co. Ltd.: Financial Performance, FY 2022 and 2023

Table 89 : Lepu Medical Technology (Beijing) Co. Ltd.: Product Portfolio

Table 90 : Mainz Biomed N.V.: Company Snapshot

Table 91 : Mainz Biomed N.V.: Financial Performance, FY 2022 and 2023

Table 92 : Mainz Biomed N.V.: Product Portfolio

Table 93 : Mainz Biomed N.V.: News/Key Developments, 2023 and 2024

Table 94 : Novigenix SA: Company Snapshot

Table 95 : Novigenix SA: Product Portfolio

Table 96 : Olympus Corp.: Company Snapshot

Table 97 : Olympus Corp.: Financial Performance, FY 2022 and 2023

Table 98 : Olympus Corp.: Product Portfolio

Table 99 : Olympus Corp.: News/Key Developments, 2024

Table 100 : Quest Diagnostics Inc.: Company Snapshot

Table 101 : Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023

Table 102 : Quest Diagnostics Inc.: Product Portfolio

Table 103 : Quest Diagnostics Inc.: News/Key Developments, 2023

Table 104 : QuidelOrtho Corp.: Company Snapshot

Table 105 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023

Table 106 : QuidelOrtho Corp.: Product Portfolio

Table 107 : QuidelOrtho Corp.: News/Key Developments, 2024

List of Figures

Summary Figure : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023

Figure 1 : Five-Year Survival Rates, by Colorectal Cancer Location

Figure 2 : Market Dynamics of Colorectal Cancer Screening and Diagnostic Testing

Figure 3 : Emerging Technologies in the Colorectal Cancer Screening and Diagnostic Testing Service Market

Figure 4 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023

Figure 5 : Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, 2021-2029

Figure 6 : Global Market for Stool DNA Tests, by Region, 2021-2029

Figure 7 : Global Market for Blood Based/Biomarker Tests, by Region, 2021-2029

Figure 8 : Global Market for Fecal Occult Blood Tests (FOBT), by Region, 2021-2029

Figure 9 : Global Market for Fecal Immunochemical Tests (FIT), by Region, 2021-2029

Figure 10 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023

Figure 11 : North American Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023

Figure 12 : U.S. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 13 : Canadian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 14 : Mexican Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 15 : European Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023

Figure 16 : German Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 17 : U.K. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 18 : French Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 19 : Italian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 20 : Spanish Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 21 : Rest of European Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 22 : Asia-Pacific Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023

Figure 23 : Chinese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 24 : Japanese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 25 : Indian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 26 : South Korean Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 27 : Australian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 28 : Rest of Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029

Figure 29 : Total Number of Key Developments and Strategies, January 2022–November 2024

Figure 30 : Partnerships and Collaborations, January 2022–November 2024

Figure 31 : Acquisitions, January 2022–November 2024

Figure 32 : Business Expansions, January 2022–November 2024

Figure 33 : Funding and Grants, January 2022–November 2024

Figure 34 : Product Approvals, Launches and Expansions, January 2022–November 2024

Figure 35 : Regulatory and Legal Activities, January 2022–November 2024

Figure 36 : Medicare and Insurance Coverage, January 2022–November 2024

Figure 37 : Snapshot of ESG Pillars

Figure 38 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 39 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 40 : Eiken Chemical Co. Ltd.: Revenue Shares, by Product Type, FY 2023

Figure 41 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 42 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 43 : Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 44 : Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 45 : Guardant Health: Revenue Shares, by Business Unit, FY 2023

Figure 46 : Guardant Health: Revenue Shares, by Country/Region, FY 2023

Figure 47 : Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Business Unit, FY 2022

Figure 48 : Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Country/Region, FY 2022

Figure 49 : Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023

Figure 50 : Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2023

Figure 51 : Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Shares, by Business Unit, FY 2023

Figure 52 : Olympus Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 53 : Olympus Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 54 : Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• バイオプラスチックの世界市場と技術 2025-03-07
• 半導体製造調査レビュー　2024年 2025-03-06
• 製造市場レビュー　2024年 2025-03-05
• 計測器とセンサの調査レビュー　2024年 2025-03-05
• 航空宇宙用先端材料の世界市場 2025-03-05

BCC Research  出版レポート一覧